Stephen W. Sorensen

TL;DR: For individuals born in the United States in 2000, the lifetime probability of being diagnosed with diabetes mellitus is substantial and primary prevention of diabetes and its complications are important public health priorities.

TL;DR: The cost-effectiveness of lifestyle intervention to prevent type 2 diabetes in high-risk individuals is within the range that American society typically finds acceptable for health care interventions.

TL;DR: Intensive glycemic control and reduction in serum cholesterol level increase costs and improve health outcomes and the cost-effectiveness ratios for these 2 interventions are comparable with several other frequently adopted health care interventions.

TL;DR: A new cost-effectiveness analysis is performed to compare universal diabetes screening (universal screening) and diabetes screening targeted to patients with hypertension (targeted screening), and the finding that intensive control of hypertension is beneficial among people with diabetes is supported.

TL;DR: In this paper, a Markov simulation model was used to estimate disease progression, costs, and quality of life of pre-diabetes patients in the U.S. and the cost-effectiveness of screening overweight and obese individuals for prediabetes and then modifying their lifestyle based on the Diabetes Prevention Program (DPP).